Brains Bioceutical is the global leader in plant-based pharmaceutical, wellness, and veterinary cannabidiol (CBD) active pharmaceutical ingredient (API) certified by UK regulatory agency MHRA.
Who We Are
We are a global leader in EU-GMP-certiﬁed production of naturally-sourced active pharmaceutical ingredients (APIs) for the pharmaceutical and nutraceutical industries. With a unique suite of licences, Brains Bioceutical is one of the only natural plant-based cannabinoid API manufacturers in commercial production today, and is involved in academic and clinical trials across the globe.
What We Do
Brains Biomedical produces CBD API product lines for the pharmaceutical and wellness sectors. With the extraordinary in our sights, our full line of plant-based CBD oils, vitamins, sprays, creams, balms, and capsules are THC-free, non-GMO, vegan, kosher, and EU-GMP certified.
Our Leadership Team
Brains Bioceutical Corp. Senior Management Team is made up of a rare hybrid of pharmaceutical and consumer goods executives, having held C-suite and other senior positions with companies such as GW Pharma, Merck, Danone, Earthbound Farms, International Herbs, Cascadia Specialties and The Royal Navy, while our medical advisory team is one of the most experienced medical advisory teams in the CBD industry.
As Brains’ wholly owned subsidiary in the UK, BSPG Laboratories is one of nine companies that has the commercial capability and EudraGMDP certiﬁcation to produce CBD API, and one in four certified to produce it from a natural, plant-based source. Brains is also manufacturing a line of phytocannabinoid THC-free CBD API products at its lab.
1st medical approved cannabis product under the 2019 ANVTSA regulations
Tested by World Anti-Doping Agency approved laboratories
EU-GMP certification for plant-based active pharmaceutical ingredient (API)